Sandy Spring Bank Armata Pharmaceuticals, Inc. Call Options Transaction History
Sandy Spring Bank
- $2.33 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARMP
# of Institutions
28Shares Held
740KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$540,9510.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$220,1400.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$208,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$92,9380.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$83,8240.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $75.2M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...